A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients

Scientific Data

Volumn 4, Issue , 2017, Pages

  Zhong, Qing ^a   Guo, Tiannan ^b   Rechsteiner, Markus ^a   Rüschoff, Jan H ^a   Rupp, Niels ^a   Fankhauser, Christian ^a   Saba, Karim ^a   Mortezavi, Ashkan ^a   Poyet, Cédric ^a   Hermanns, Thomas ^a   Zhu, Yi ^b   Moch, Holger ^a   Aebersold, Ruedi ^b,c   Wild, Peter J ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; PROSTATE TUMOR; PROSTATECTOMY; PROTEOMICS;

GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTEOMICS; PTEN PHOSPHOHYDROLASE;

EID: 85015420724     PISSN: None     EISSN: 20524463     Source Type: Journal    
DOI: 10.1038/sdata.2017.14     Document Type: Article

References (22)

1. Swanton, C. Intratumor heterogeneity: evolution through space and time. Cancer. Res. 72, 4875-4882 (2012)
2. Marusyk, A., Almendro, V. & Polyak, K. Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer. 12, 323-334 (2012)
3. Longo, D. L. Tumor heterogeneity and personalized medicine. N. Engl. J. Med. 366, 956-957 (2012)
4. Cancer Genome Atlas Research, N.et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120 (2013)
5. Guo, T. et al. Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat. Med. 21, 407-413 (2015)
6. Zhong, Q. et al. Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Sci. Rep. 6, 24146 (2016)
7. Wolff, A. C. et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch. Pathol. Lab. Med. 131, 18-43 (2007)
8. Fuchs, T. J. & Buhmann, J. M. Computational pathology: challenges and promises for tissue analysis. Comput. Med. Imaging. Graph. 35, 515-530 (2011)
9. Zhong, Q., Busetto, A. G., Fededa, J. P., Buhmann, J. M. & Gerlich, D. W. Unsupervised modeling of cell morphology dynamics for time-lapse microscopy. Nat. Methods. 9, 711-713 (2012)
10. Cima, I. et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. USA 108, 3342-3347 (2011)
11. Beck, A. H. et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci. Transl. Med. 3, 108ra113 (2011)
12. Yuan, Y. et al. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci. Transl. Med. 4, 157ra143 (2012)
13. Mortezavi, A. et al. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin. Cancer. Res. 17, 1111-1121 (2011)
14. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012)
15. Blattner, M. et al. SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia 16, 14-20 (2014)
16. Haldrup, C. et al. DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. J. Clin. Oncol. 31, 3250-3258 (2013)
17. Kristensen, H. et al. Hypermethylation of the GABRE ∼miR-452 ∼miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clin. Cancer. Res. 20, 2169-2181 (2014)
18. Krohn, A. et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. Am. J. Pathol. 181, 401-412 (2012)
19. Duda, R. O. & Hart, P. E. Use of the Hough transformation to detect lines and curves in pictures. Commun. ACM. 15, 11-15 (1972)
20. Cortes, C. & Vapnik, V. Support-Vector Networks. Mach. Learn. 20, 273-297 (1995)
21. Chang, C.-C. & Lin, C.-J. LIBSVM: A library for support vector machines. ACM Trans. Intell. Syst. Technol. 2, 1-27 (2011)
22. Schuffler, P. J. et al. TMARKER: A free software toolkit for histopathological cell counting and staining estimation. J. Path. Inform 4, S2 (2013)